Results 161 to 170 of about 62,013 (267)

Association of Proton Pump Inhibitor and Potassium‐Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5‐Aminosalicylic Acid in Patients With Ulcerative Colitis

JGH Open, Volume 10, Issue 2, February 2026.
ABSTRACT Aims Proton pump inhibitors (PPIs) and potassium‐competitive acid blockers (PCABs) are widely used for acid‐related disorders. Recent studies have raised concerns that acid suppression may alter gut microbiota and drug pharmacokinetics, potentially influencing therapeutic outcomes in patients with inflammatory bowel disease.
Shinsuke Otagiri, Takahiro Ito, Keiji Yagisawa, Ayumu Sugitani, Atsuo Maemoto   +4 more
wiley   +1 more source

Cost-effectiveness analysis of second intravenous immunoglobulin infusion versus infliximab for treating IVIG-resistant Kawasaki disease patients. [PDF]

Cost Eff Resour Alloc
Johnson JM, Simpson KN, Simpson AN, Tremoulet AH, Burns JC.   +4 more
europepmc   +1 more source

Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease. [PDF]

J Clin Med
Saraga A, Deyhim T, Gade A, Geeganage G, Soliman M, Rothschild NDV, Zullow S, Rabinowitz LG, Grossberg LB, Cheifetz AS, Papamichael K.   +10 more
europepmc   +1 more source

P445 Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy [PDF]

, 2014
R. Monterubbianesi, A. Aratari, A. Armuzzi, Marco Daperno, L. Biancone, M. Cappello, V. Annese, G. Riegler, A. Orlando, A. Viscido, G.M. Meucci, A. Gasbarrini, L. Guidi, A. Lavagna, R. Sostegni, S. Onali, C. Papi, A. Kohn   +17 more
openalex   +1 more source

Anti‐tumor necrosis factor‐α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real‐life study

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 2, Page 454-464, February 2026.
Abstract Objectives The aim of the study is to evaluate the efficacy of anti‐tumor necrosis factor (TNF)‐α monotherapy versus combination anti‐TNF‐α and immunosuppressive therapy. Methods A single‐center, retrospective, observational study was conducted on inflammatory bowel disease (IBD) children.
Flora Fedele, Massimo Martinelli, Caterina Strisciuglio, Elena Scarpato, Annamaria Staiano, Erasmo Miele   +5 more
wiley   +1 more source

Pharmacokinetics and Exposure-Response During Infliximab Induction Therapy in Pediatric IBD Using Point-of-Care Assay. [PDF]

J Clin Med
Hemperly A, Yang J, Ta A, Vande Casteele N.   +3 more
europepmc   +1 more source

P1107 Biosimilar but not quite the same?: Post-induction levels of infliximab differ between brands [PDF]

Prashant Patel, M Love, Peter J. Rimmer, Rachel Cooney, Karl Hazel   +4 more
openalex   +1 more source

Using machine learning to predict clinical remission with exclusive enteral nutrition in pediatric Crohn disease

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 2, Page 465-476, February 2026.
Abstract Objectives Exclusive enteral nutrition (EEN) is a first‐line treatment for induction of remission in luminal pediatric Crohn disease (pCD). However, as the efficacy of EEN varies from patient to patient, there is a need to distinguish between responders and nonresponding patients. This study had two aims.
Ricardo G. Suarez Suarez, Daniel G. McClement, Roberto Vega, Hien Q. Huynh, Ayub Shaikh, Anthony Otley, Kevan Jacobson, Mary Sherlock, David R. Mack, Colette Deslandres, Wael El‐Matary, Eileen Crowley, Jennifer deBruyn, Thomas Walters, Anne M. Griffiths, Russell Greiner, Eytan Wine, The Canadian Children IBD Network, Jeff Critch, Lara Hart, Rilla Schneider, Kevin Bax, Eric I. Benchimol   +22 more
wiley   +1 more source

Comparison of the protective effects of infliximab and splenectomy on hepatic ischemia-reperfusion injury in rats: an experimental study. [PDF]

J Yeungnam Med Sci
Lee S, Lee D, Jang Y, Lim DG, Kwak KH, Jung H, Choi EK.   +6 more
europepmc   +1 more source

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County [PDF]

, 2004
T Ljung, P Karlén, D Schmidt, P M Hellström, A Lapidus, I Janczewska, U Sjöqvist, R Löfberg   +7 more
openalex   +1 more source